GoodRx Holdings, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by GoodRx Holdings, Inc. on February 27, 2026, covering events occurring on February 26, 2026. The report addresses a change in the composition of the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance matters and does not contain financial performance data.
Material Changes
The material change reported is the departure of Dipanjan Deb from the Board of Directors, effective February 26, 2026. Mr. Deb notified the Company of his resignation, stating that the decision was not the result of any disagreement with the Company or its management regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies beyond the standard disclosure regarding the director's resignation.
Key Facts for Investor Verification
- Dipanjan Deb resigned as a member of the Board of Directors effective February 26, 2026.
- The resignation was voluntary and not due to any disagreement with the Company.
- The report was signed by Christopher McGinnis, Chief Financial Officer & Treasurer.
- No financial results or operational metrics are disclosed in this specific filing.